EcoDrugPlus

Ensembl ID : ENSNGAG00000013469
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Ensembl ID : ENSNGAG00000017697
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSNGAG00000021918
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSNGAG00000019141
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Ensembl ID : ENSNGAG00000023639
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSNGAG00000020506
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSNGAG00000003647
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSNGAG00000015348
Gene Symbol: -
Cross references: -
37 Possible Orthologues:

Ensembl ID : ENSNGAG00000011864
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSNGAG00000016079
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSNGAG00000020737
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSNGAG00000011632
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).